Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,221 | -7,177 | -4,565 | -2,139 | -3,713 |
| Depreciation Amortization | 42 | 52 | 20 | 10 | 1 |
| Accounts payable and accrued liabilities | -126 | -185 | -116 | -154 | 336 |
| Other Working Capital | 244 | 134 | 62 | -233 | 398 |
| Other Operating Activity | 2,100 | 1,632 | 663 | 428 | -11 |
| Operating Cash Flow | $-7,961 | $-5,545 | $-3,935 | $-2,089 | $-2,988 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -289 | -289 | -258 | -193 | -94 |
| Investing Cash Flow | $-289 | $-289 | $-258 | $-193 | $-94 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -24 |
| Common Stock Issued | N/A | 0 | N/A | N/A | 15,405 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -1,883 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $13,498 |
| Beginning Cash Position | 10,840 | 10,840 | 10,840 | 10,840 | 424 |
| End Cash Position | 2,591 | 5,007 | 6,648 | 8,558 | 10,840 |
| Net Cash Flow | $-8,250 | $-5,834 | $-4,193 | $-2,282 | $10,416 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,961 | -5,545 | -3,935 | -2,089 | -2,988 |
| Capital Expenditure | -289 | -289 | -258 | -193 | -94 |
| Free Cash Flow | -8,250 | -5,834 | -4,193 | -2,282 | -3,082 |